GG 537 (Bromocriptine Mesylate 5 mg)
Pill with imprint GG 537 is White & Yellow, Capsule-shape and has been identified as Bromocriptine Mesylate 5 mg. It is supplied by Sandoz Pharmaceuticals Inc.
Bromocriptine is used in the treatment of acromegaly; hyperprolactinemia; diabetes, type 2; parkinson's disease and belongs to the drug classes dopaminergic antiparkinsonism agents, prolactin inhibitors. There is no proven risk in humans during pregnancy. Bromocriptine 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GG 537
Bromocriptine Mesylate
- Imprint
- GG 537
- Strength
- 5 mg
- Color
- White & Yellow
- Size
- 16.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents, Prolactin inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00781-2119 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
gelatin,
lactose,
magnesium stearate,
ferric oxide red,
sodium lauryl sulfate,
corn starch,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
More about bromocriptine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (28)
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: dopaminergic antiparkinsonism agents
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.